These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9213698)

  • 1. [What is happening with the institution for drug information scrutiny?].
    Håkansson J; Hensjö LO
    Lakartidningen; 1997 Jun; 94(24):2259-60. PubMed ID: 9213698
    [No Abstract]   [Full Text] [Related]  

  • 2. [Scrutiny of drug marketing by drug industry].
    Perman E
    Lakartidningen; 2003 Apr; 100(16):1444-5. PubMed ID: 12756713
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug handling is unreasonable in Sweden].
    Fichtelius KE
    Lakartidningen; 1993 Dec; 90(50):4534. PubMed ID: 8264284
    [No Abstract]   [Full Text] [Related]  

  • 4. [Quick drug investigations; desirable, useful and steady work].
    Olofsson C
    Vardfacket; 1978 Aug; 2(15):42-5. PubMed ID: 250385
    [No Abstract]   [Full Text] [Related]  

  • 5. [How to improve drug information!].
    Järhult B
    Lakartidningen; 1998 Jul; 95(30-31):3278-9. PubMed ID: 9715057
    [No Abstract]   [Full Text] [Related]  

  • 6. [The Board for Evaluation of Drug Information: "Cognex clinics" are not popular. Guidelines for a new type of information].
    Lakartidningen; 1997 Jan; 94(1-2):32. PubMed ID: 9053600
    [No Abstract]   [Full Text] [Related]  

  • 7. [Who will choose patients' medication in the future? Independent information must be strengthened II].
    Liedholm H; Linné AB; Ekedahl A
    Lakartidningen; 1996 Jun; 93(24):2315-7. PubMed ID: 8684030
    [No Abstract]   [Full Text] [Related]  

  • 8. [Physicians and pharmacists should cooperate more and more! It is beneficial for independent drug information].
    Nilsson JL
    Lakartidningen; 1996 Apr; 93(16):1507-8. PubMed ID: 8667740
    [No Abstract]   [Full Text] [Related]  

  • 9. [Astra companies break the existing rules].
    Olsson B
    Lakartidningen; 1996 Apr; 93(15):1416. PubMed ID: 8667727
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drugs and the public--an example of asymmetrical information].
    Hanson J
    Lakartidningen; 2001 Dec; 98(51-52):5922. PubMed ID: 11806273
    [No Abstract]   [Full Text] [Related]  

  • 11. [The inspection of information: "Hidden" comparison, words of evaluation often cause notifications].
    Lakartidningen; 1996 Aug; 93(32-33):2763-5. PubMed ID: 8765603
    [No Abstract]   [Full Text] [Related]  

  • 12. [A serious discussion concerning p-pills is needed].
    Samuelsson E; Hägg S; Håkanson J
    Lakartidningen; 1997 Jul; 94(28-29):2530. PubMed ID: 9254311
    [No Abstract]   [Full Text] [Related]  

  • 13. [Views on marketing of a neuroleptic agent].
    Bendz H
    Lakartidningen; 1999 Nov; 96(47):5191-2. PubMed ID: 10608107
    [No Abstract]   [Full Text] [Related]  

  • 14. [Worry about the IGM is not justified].
    Mandahl H
    Lakartidningen; 1997 Jul; 94(28-29):2529. PubMed ID: 9254309
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prohibited marketing and shift in meaning of indications--a case for the IGM].
    Perman E
    Lakartidningen; 2003 Jul; 100(28-29):2378-9. PubMed ID: 12899031
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug information residency rotation with pharmaceutical industry.
    Cramer RL
    Am J Pharm Educ; 1986; 50(2):154-6. PubMed ID: 10277398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Why this arrogance, Josef Milerad?].
    Olin GA
    Lakartidningen; 2003 Jan; 100(4):254-5. PubMed ID: 12580016
    [No Abstract]   [Full Text] [Related]  

  • 18. [A reply on ALLHAT: changed text in the Fass and ongoing debate is necessary for a good care of hypertension].
    Järhult B; Lindahl SO
    Lakartidningen; 2003 May; 100(22):1993-4. PubMed ID: 12833732
    [No Abstract]   [Full Text] [Related]  

  • 19. [Shoot the messenger!--or the art of changing the subject of conversation].
    Zackrisson B
    Lakartidningen; 2003 Jan; 100(4):252-3. PubMed ID: 12580015
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.
    Strawn MN
    J Contemp Health Law Policy; 2003; 19(2):495-520. PubMed ID: 14748255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.